Cutting edge: The NLRP3 inflammasome links complement-mediated inflammation and IL-1β release

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 1006-1010

  Laudisi, Federica ^a   Spreafico, Roberto ^a   Evrard, Maximilien ^a   Hughes, Timothy R ^b   Mandriani, Barbara ^a   Kandasamy, Matheswaran ^c   Morgan, B Paul ^b   Sivasankar, Baalasubramanian ^c   Mortellaro, Alessandra ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ASC PROTEIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; COMPLEMENT SYSTEM; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BONE MARROW CELLS; CARRIER PROTEINS; CASPASE 1; CELLS, CULTURED; COMPLEMENT C6; COMPLEMENT SYSTEM PROTEINS; DENDRITIC CELLS; ENZYME ACTIVATION; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; SIGNAL TRANSDUCTION;

EID: 84880667818     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300489     Document Type: Article

References (20)

1. Hänsch, G. M., M. Seitz, G. Martinotti, M. Betz, E. W. Rauterberg, and D. Gemsa. 1984. Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. J. Immunol. 133: 2145-2150.
2. Godau, J., T. Heller, H. Hawlisch, M. Trappe, E. Howells, J. Best, J. Zwirner, J. S. Verbeek, P. M. Hogarth, C. Gerard, et al. 2004. C5a initiates the inflammatory cascade in immune complex peritonitis. J. Immunol. 173: 3437-3445.
3. Markiewski, M. M., and J. D. Lambris. 2007. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 171: 715-727.
4. Fang, C., X. Zhang, T. Miwa, and W. C. Song. 2009. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production. Blood 114: 1005-1015.
5. Zhang, X., Y. Kimura, C. Fang, L. Zhou, G. Sfyroera, J. D. Lambris, R. A. Wetsel, T. Miwa, and W. C. Song. 2007. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110: 228-236.
6. Rathinam, V. A., S. K. Vanaja, and K. A. Fitzgerald. 2012. Regulation of inflammasome signaling. Nat. Immunol. 13: 333-2.
7. Bauernfeind, F. G., G. Horvath, A. Stutz, E. S. Alnemri, K. MacDonald, D. Speert, T. Fernandes-Alnemri, J. Wu, B. G. Monks, K. A. Fitzgerald, et al. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183: 787-791.
8. Zambetti, L. P., F. Laudisi, G. Licandro, P. Ricciardi-Castagnoli, and A. Mortellaro. 2012. The rhapsody of NLRPs: master players of inflammation..and a lot more. Immunol. Res. 53: 78-90.
9. Franchi, L., R. Munoz-Planillo, and G. Núnez. 2012. Sensing and reacting to microbes through the inflammasomes. Nat. Immunol. 13: 325-332.
10. Mariathasan, S., D. S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W. P. Lee, Y. Weinrauch, D. M. Monack, and V. M. Dixit. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232.
11. Martinon, F., V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
12. Morgan, B. P., J. Chamberlain-Banoub, J. W. Neal, W. Song, M. Mizuno, and C. L. Harris. 2006. The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice. Clin. Exp. Immunol. 146: 294-302.
13. Conforti-Andreoni, C., R. Spreafico, H. L. Qian, N. Riteau, B. Ryffel, P. Ricciardi-Castagnoli, and A. Mortellaro. 2011. Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18. J. Immunol. 187: 5842-5850.
14. Iyer, S. S., W. P. Pulskens, J. J. Sadler, L. M. Butter, G. J. Teske, T. K. Ulland, S. C. Eisenbarth, S. Florquin, R. A. Flavell, J. C. Leemans, and F. S. Sutterwala. 2009. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. USA 106: 20388-20393.
15. Zhao, L., Y. Ohtaki, K. Yamaguchi, M. Matsushita, T. Fujita, T. Yokochi, H. Takada, and Y. Endo. 2002. LPS-induced platelet response and rapid shock in mice: contribution of O-Antigen region of LPS and involvement of the lectin pathway of the complement system. Blood 100: 3233-3239.
16. Lewis, R. D., C. L. Jackson, B. P. Morgan, and T. R. Hughes. 2010. The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice. Mol. Immunol. 47: 1098-1105.
17. Berger, S. P., and M. R. Daha. 2007. Complement in glomerular injury. Semin. Immunopathol. 29: 375-384.
18. Pickering, M. C., J. Warren, K. L. Rose, F. Carlucci, Y. Wang, M. J. Walport, H. T. Cook, and M. Botto. 2006. Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc. Natl. Acad. Sci. USA 103: 9649-9654.
19. Zuber, J., F. Fakhouri, L. T. Roumenina, C. Loirat, and V. Frémeaux-Bacchi; French Study Group for aHUS/C3G. 2012. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat. Rev. Nephrol. 8: 643-657.
20. Bomback, A. S., R. J. Smith, G. R. Barile, Y. Zhang, E. C. Heher, L. Herlitz, M. B. Stokes, G. S. Markowitz, V. D. D'Agati, P. A. Canetta, et al. 2012. Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin. J. Am. Soc. Nephrol. 7: 748-756.